Idorsia Management
Management criteria checks 3/4
Idorsia's CEO is Jean-Paul Clozel, appointed in Jan 2017, has a tenure of 7.33 years. total yearly compensation is CHF2.73M, comprised of 27.5% salary and 72.5% bonuses, including company stock and options. directly owns 20.03% of the company’s shares, worth CHF72.13M. The average tenure of the management team and the board of directors is 6.9 years and 4 years respectively.
Key information
Jean-Paul Clozel
Chief executive officer
CHF2.7m
Total compensation
CEO salary percentage | 27.5% |
CEO tenure | 7.3yrs |
CEO ownership | 20.0% |
Management average tenure | 6.9yrs |
Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -CHF374m |
Jun 30 2023 | n/a | n/a | -CHF814m |
Mar 31 2023 | n/a | n/a | -CHF843m |
Dec 31 2022 | CHF3m | CHF750k | -CHF828m |
Sep 30 2022 | n/a | n/a | -CHF887m |
Jun 30 2022 | n/a | n/a | -CHF810m |
Mar 31 2022 | n/a | n/a | -CHF728m |
Dec 31 2021 | CHF3m | CHF750k | -CHF635m |
Sep 30 2021 | n/a | n/a | -CHF520m |
Jun 30 2021 | n/a | n/a | -CHF499m |
Mar 31 2021 | n/a | n/a | -CHF429m |
Dec 31 2020 | CHF3m | CHF750k | -CHF445m |
Compensation vs Market: Jean-Paul's total compensation ($USD3.01M) is above average for companies of similar size in the UK market ($USD1.04M).
Compensation vs Earnings: Jean-Paul's compensation has been consistent with company performance over the past year.
CEO
Jean-Paul Clozel (68 yo)
7.3yrs
Tenure
CHF2,725,271
Compensation
Mr. Jean-Paul Clozel, M.D., co- founded Actelion Ltd (alternate name Actelion AG ) in 1997 and has been its Chief Executive Officer since 1999. He is Executive Director at Idorsia Ltd. Mr. Clozel serves as...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 7.3yrs | CHF2.73m | 20.03% CHF 72.1m | |
Executive VP & CFO | 7.3yrs | no data | 0.053% CHF 190.7k | |
Executive VP & Chief Scientific Officer | 7.3yrs | no data | 7.14% CHF 25.7m | |
Senior VP and Head of Investor Relations & Corporate Communications | 6.9yrs | no data | no data | |
Senior VP | 1.5yrs | no data | no data | |
Senior VP & Head of Global Human Resources | 6.9yrs | no data | no data | |
Executive VP & Chief Medical Officer | no data | no data | 0.11% CHF 392.5k | |
Senior VP & Head of Technical Operations | no data | no data | no data | |
Senior VP & Head of Drug Discovery Biology | no data | no data | no data | |
Senior VP & Head of Drug Discovery Chemistry | no data | no data | no data | |
Executive VP & Head of Global Clinical Development | 5.3yrs | no data | 0.0027% CHF 9.5k |
6.9yrs
Average Tenure
60yo
Average Age
Experienced Management: 0RQE's management team is seasoned and experienced (6.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | no data | CHF2.73m | 20.03% CHF 72.1m | |
Non-Executive Director | 3yrs | CHF148.88k | 0.0061% CHF 22.1k | |
Non-Executive Director | 4yrs | CHF158.04k | 0.0082% CHF 29.4k | |
Non-Executive Director | 4yrs | CHF176.73k | 0.039% CHF 142.0k | |
Non-Executive Chairman | 5yrs | CHF347.12k | 0.037% CHF 131.8k | |
Non-Executive Director | less than a year | no data | no data | |
Non-Executive Director | 4yrs | CHF168.61k | 0.015% CHF 52.2k | |
Non-Executive Director | 3yrs | CHF164.24k | 0.011% CHF 37.8k |
4.0yrs
Average Tenure
65yo
Average Age
Experienced Board: 0RQE's board of directors are considered experienced (4 years average tenure).